Fabiano Flauto

Via Sergio Pansini, 5
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Adjuvant mitotane in low-risk adrenocortical carcinoma: A reconstructed IPD analysis of the ADIUVO randomized and observational studies.

Adjuvant mitotane in low-risk adrenocortical carcinoma: A reconstructed IPD analysis of the ADIUVO randomized and observational studies.

Journal: Critical reviews in oncology/hematology
Published: April 06, 2026

The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study.

The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study.

Journal: The oncologist
Published: February 08, 2026

Case Report: TPR-ALK fusion-positive inflammatory myofibroblastic tumour treated with sequential ALK inhibitors.

Case Report: TPR-ALK fusion-positive inflammatory myofibroblastic tumour treated with sequential ALK inhibitors.

Journal: Frontiers in oncology
Published: December 30, 2025

Salvage radiotherapy with or without hormonal therapy for biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis.

Salvage radiotherapy with or without hormonal therapy for biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis.

Journal: Prostate cancer and prostatic diseases
Published: December 23, 2025

Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.

Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.

Journal: Cancers
Published: June 13, 2025

The Efficacy and Safety of Multi-Kinase Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.

The Efficacy and Safety of Multi-Kinase Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.

Journal: Cancers
Published: May 11, 2025

Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis.

Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis.

Journal: European urology oncology
Published: April 08, 2025

The management of adrenocortical carcinoma in the era of precision medicine.

The management of adrenocortical carcinoma in the era of precision medicine.

Journal: Critical reviews in oncology/hematology
Published: March 31, 2025

New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative review.

New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative review.

Journal: Chinese clinical oncology
Published: March 26, 2025

Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology.

Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology.

Journal: Frontiers in oncology
Published: November 06, 2024

A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma.

A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma.

Journal: Cancers
Published: October 22, 2024

Malignant granular cell tumor of chest wall: a case report.

Malignant granular cell tumor of chest wall: a case report.

Journal: Frontiers in oncology
Published: July 15, 2024
Showing 1-12 of 12

Last Updated: 09/26/2026